# Genzyme Corporation – FDA Inspection, Feb 14, 2025

Source: https://www.keypedia.com/records/fda_inspections/genzyme-corporation/abd12bcb-8957-45b8-b0a5-611ccb2bdf41
Source feed: FDA_Inspections

> FDA inspection 1261312 of Genzyme Corporation, February 14, 2025. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261312
- Company Name: Genzyme Corporation
- Inspection Date: 2025-02-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: New England District Office
- Citation Count: 3

## Related Documents

- FDA Inspection 1281578 - 2025-08-14
- FDA Inspection 1120993 - 2020-02-28
- FDA Inspection 1062695 - 2018-07-19
- [FDA Inspection 985381 - 2016-08-18](https://www.keypedia.com/records/fda_inspections/genzyme-corporation/d555abbb-6d54-45b1-952c-255134546f9d)
- FDA Inspection 896910 - 2014-09-18

## Related Officers

- [FDA Personnel](https://www.keypedia.com/people/lizaida-perez/686fbdca-bfd7-4a73-990a-d8a97e6b88b7)
- [Company Rep](https://www.keypedia.com/people/priscilla-m-pastrana/170080d1-49da-42d7-8615-c774cac9f7ec)

Company: https://www.keypedia.com/companies/genzyme-corporation/f157f5fd-aee3-4994-b098-37af3a503a02

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144
